Skip to content
Future of British Business

Oxford Biomedica Signs Covid Shot Deal With AstraZeneca

Vials of AstraZeneca’s Covid-19 vaccine.

Vials of AstraZeneca’s Covid-19 vaccine.

Photographer: Dimas Ardian/Bloomberg
Updated on

Oxford Biomedica Plc has signed a three-year agreement with AstraZeneca Plc to manufacture the UK drug giant’s Covid-19 vaccine on an as-needed basis. 

The agreement is an extension of the original supply and development agreement signed between the two companies in September 2020, as the coronavirus swept around the world, according to a statement Friday.